News and developments

Homburger advised Alcon Inc. on USD 1.32 bn revolving credit facility

On October 27, 2023, Alcon Inc. (SIX: ALC), a leading eye care product company, in its capacity as Borrower and Guarantor entered into a USD 1.32 bn revolving credit facilities agreement with, among others, Citibank, N.A., London Branch, BNP PARIBAS (SUISSE) SA, Bank of America Europe Designated Activity Company, Deutsche Bank Luxembourg S.A., GOLDMAN SACHS BANK USA, J.P. Morgan Securities plc, Morgan Stanley Bank International Limited, Sumitomo Mitsui Banking Corporation and UBS Switzerland AG each as an Arranger and CITIBANK EUROPE PLC, UK BRANCH as Agent as part of a syndicate of 17 international banks acting as Original Lenders.

Homburger advised Alcon Inc. as Borrower and Guarantor as well as its subsidiary Alcon Pharmaceuticals Ltd as Borrower with regard to all legal aspects of the financing transaction.

The Homburger team is led by Frank Gerhard (Corporate / M&A) and comprised Jürg Frick and Nathalie Scherrer (both Financing and Investment Products) as well as Stefan Oesterhelt (Tax).